id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3200-0003,FDA,FDA-2019-E-3200,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2019-10-29T04:00:00Z,2019,10,2019-10-29T04:00:00Z,,2019-10-29T20:16:06Z,,0,0,0900006484106cea
FDA-2019-E-3200-0001,FDA,FDA-2019-E-3200,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-07-02T04:00:00Z,2019,7,2019-07-02T04:00:00Z,,2019-07-02T16:55:08Z,,0,0,0900006483d57f14
FDA-2019-E-3200-0002,FDA,FDA-2019-E-3200,"Patent Extension Application from Servilla Whitney LLC (on behalf of Amicus Therapeutics, Inc.)",Other,Application,2019-07-02T04:00:00Z,2019,7,2019-07-02T04:00:00Z,,2019-07-02T16:58:18Z,,0,0,0900006483d57f15